| 25/07/15 |
Name |
Symbol |
25/07/15 |
Shares |
Cost basis |
Mkt value▼ |
Gain |
Overall return |
|
Adler Real Estate AG |
ADL |
15.18* |
500 |
5,787.27 |
7,587.50 |
+1,800.23 |
31.11% |
|
Akorn, Inc. |
AKRX |
45.39 |
120 |
$4,491.15 |
$5,446.80 |
+$955.65 |
19.43% |
|
Staffline Group Plc |
STAF |
1,477.00 |
207 |
£1,621.76 |
£2,939.40 |
+£1,317.64 |
81.25% |
|
Drillisch AG |
DRI |
38.44* |
81 |
1,999.31 |
3,113.24 |
+1,113.92 |
55.72% |
|
Regeneron Pharmaceutical... |
REGN |
541.85 |
4 |
$2,114.93 |
$2,167.40 |
+$52.47 |
2.48% |
|
Ashtead Group plc |
AHT |
940.00 |
150 |
£1,433.63 |
£1,410.00 |
-£23.63 |
-1.65% |
|
|
|
|
|
|
|
|
|
|
Cash - Deposit / Withdraw |
|
|
|
13,183,37 |
|
|
|
Portfolio value: |
|
|
36,208.80 |
+5,435.30 |
27.85% |
Portfolio return in the last 12 monthe is up to 26.7%.
In order to re-allocate our assets we sold part of our shares in Akorn.
Our Tactical Asset Allocation is now aimed to: 68% stock + 32% cash
This week Ashtead Group brought us some bad news. We lost nearly -13% on our position.
Time to buy it for your own portfolio ?
|
